Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials

被引：52
|
作者：
Choi, I. [2 ]
Tanosaki, R. [3 ]
Uike, N. [2 ]
Utsunomiya, A. [4 ]
Tomonaga, M. [5 ]
Harada, M. [6 ]
Yamanaka, T.
Kannagi, M. [7 ]
Okamura, J. [1 ]
机构：
[1] Kyushu Natl Canc Ctr, Inst Clin Res, Minami Ku, Fukuoka 8111395, Japan
[2] Kyushu Natl Canc Ctr, Dept Hematol, Fukuoka 8111395, Japan
[3] Natl Canc Ctr, Stem Cell Transplantat Unit, Tokyo, Japan
[4] Imamura Bun In Hosp, Dept Hematol, Kagoshima, Japan
[5] Nagasaki Univ, Mol Med Unit, Dept Hematol, Atom Bomb Dis Inst,Sch Med, Nagasaki 852, Japan
[6] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan
[7] Tokyo Med & Dent Univ, Div Med Res, Dept Immunotherapeut, Tokyo, Japan
来源：
BONE MARROW TRANSPLANTATION | 2011年 / 46卷 / 01期
基金：
日本学术振兴会;
关键词：
adult T-cell leukemia/lymphoma; allogeneic hematopoietic SCT; reduced-intensity conditioning regimen; HTLV-1 proviral load; RETROSPECTIVE ANALYSIS; LEUKEMIA-LYMPHOMA; TRANSPLANTATION; INTENSITY; IMPACT;
D O I：
10.1038/bmt.2010.92
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
We have previously conducted clinical trials of allogeneic hematopoietic SCT with reduced-intensity conditioning regimen (RIC) for adult T-cell leukemia/lymphoma (ATLL)-a disease caused by human T-lymphotropic virus type 1 (HTLV-1) infection and having a dismal prognosis. Long-term follow-up studies of these trials revealed that 10 of the 29 patients have survived for a median of 82 months (range, 54-100 months) after RIC, indicating a possible curability of the disease by RIC. However, we have also observed that the patterns of post-RIC changes in HTLV-1 proviral load over time among the 10 survivors were classified into three patterns. This is the first report to clarify the long-term outcomes after RIC for ATLL patients. Bone Marrow Transplantation (2011) 46, 116-118; doi:10.1038/bmt.2010.92; published online 19 April 2010
引用
收藏
页码：116 / 118
页数：3
相关论文
共 50 条
  • [1] Long-term outcomes after hematopoietic SCT for adult T-cell leukemia/lymphoma: results of prospective trials
    I Choi
    R Tanosaki
    N Uike
    A Utsunomiya
    M Tomonaga
    M Harada
    T Yamanaka
    M Kannagi
    J Okamura
    Bone Marrow Transplantation, 2011, 46 : 116 - 118
  • [2] Hematopoietic SCT for adult T-cell leukemia/lymphoma: a review
    Jabbour, M.
    Tuncer, H.
    Castillo, J.
    Butera, J.
    Roy, T.
    Pojani, J.
    Al-Malki, M.
    Al-Homsi, A. S.
    BONE MARROW TRANSPLANTATION, 2011, 46 (08) : 1039 - 1044
  • [3] Long-term study of indolent adult T-cell leukemia-lymphoma
    Takasaki, Yumi
    Iwanaga, Masako
    Imaizumi, Yoshitaka
    Tawara, Masayuki
    Joh, Tatsuro
    Kohno, Tomoko
    Yamada, Yasuaki
    Kamihira, Shimeru
    Ikeda, Schuichi
    Miyazaki, Yasushi
    Tomonaga, Masao
    Tsukasaki, Kunihiro
    BLOOD, 2010, 115 (22) : 4337 - 4343
  • [4] Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: the Nagasaki Transplant Group experience
    Itonaga, Hidehiro
    Tsushima, Hideki
    Taguchi, Jun
    Fukushima, Takuya
    Taniguchi, Hiroaki
    Sato, Shinya
    Ando, Koji
    Sawayama, Yasushi
    Matsuo, Emi
    Yamasaki, Reishi
    Onimaru, Yasuyuki
    Imanishi, Daisuke
    Imaizumi, Yoshitaka
    Yoshida, Shinichiro
    Hata, Tomoko
    Moriuchi, Yukiyoshi
    Uike, Naokuni
    Miyazaki, Yasushi
    BLOOD, 2013, 121 (01) : 219 - 225
  • [5] Cord Blood Transplantation Provided Long-term Remission in a Case of Adult T-cell Leukemia-lymphoma (ATL) with Myelofibrosis
    Itonaga, Hidehiro
    Taguchi, Jun
    Kato, Takeharu
    Sato, Shinya
    Sawayama, Yasushi
    Imaizumi, Yoshitaka
    Niino, Daisuke
    Hata, Tomoko
    Fukushima, Takuya
    Ohshima, Koichi
    Miyazaki, Yasushi
    INTERNAL MEDICINE, 2016, 55 (02) : 197 - 201
  • [6] Adult T-cell leukemia/lymphoma
    Oliveira, Pedro Dantas
    Farre, Lourdes
    Bittencourt, Achilea Lisboa
    REVISTA DA ASSOCIACAO MEDICA BRASILEIRA, 2016, 62 (07): : 691 - 700
  • [7] Adult T-Cell Leukemia/Lymphoma
    Mehta-Shah, Neha
    Ratner, Lee
    Horwitz, Steven M.
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (08) : 487 - +
  • [8] Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia-lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group
    Itonaga, H.
    Sawayama, Y.
    Taguchi, J.
    Honda, S.
    Taniguchi, H.
    Makiyama, J.
    Matsuo, E.
    Sato, S.
    Ando, K.
    Imanishi, D.
    Imaizumi, Y.
    Yoshida, S.
    Hata, T.
    Moriuchi, Y.
    Fukushima, T.
    Miyazaki, Y.
    BONE MARROW TRANSPLANTATION, 2015, 50 (04) : 585 - 591
  • [9] Therapeutic Options for Adult T-Cell Leukemia/Lymphoma
    Marcais, Ambroise
    Suarez, Felipe
    Sibon, David
    Frenzel, Laurent
    Hermine, Olivier
    Bazarbachi, Ali
    CURRENT ONCOLOGY REPORTS, 2013, 15 (05) : 457 - 464
  • [10] Successful treatment by donor lymphocyte infusion of adult T-cell leukemia/lymphoma relapse following allogeneic hematopoietic stem cell transplantation
    Kamimura, Tomohiko
    Miyamoto, Toshihiro
    Kawano, Noriaki
    Numata, Akihiko
    Ito, Yoshikiyo
    Chong, Yong
    Nagafuji, Koji
    Teshima, Takanori
    Hayashi, Shin
    Akashi, Koichi
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2012, 95 (06) : 725 - 730
12345